Dexmedetomidine 0.25 μg/kg/hr	Dexmedetomidine 0.75 μg/kg/hr	Ramsay Sedation Scale score	1066	1330	Systolic blood pressure, heart rate, and SpO2 were decreased, and RSS score was increased significantly at both 20 min and 40 min after injection of dexmedetomidine in the three study groups compared to baseline, without significant differences between the groups.
Dexmedetomidine 0.25 μg/kg/hr	Dexmedetomidine 0.50 μg/kg/hr	Systolic blood pressure	1066	1329	Systolic blood pressure, heart rate, and SpO2 were decreased, and RSS score was increased significantly at both 20 min and 40 min after injection of dexmedetomidine in the three study groups compared to baseline, without significant differences between the groups
Dexmedetomidine 0.25 μg/kg/hr	Dexmedetomidine 0.75 μg/kg/hr	Systolic blood pressure	1066	1330	Systolic blood pressure, heart rate, and SpO2 were decreased, and RSS score was increased significantly at both 20 min and 40 min after injection of dexmedetomidine in the three study groups compared to baseline, without significant differences between the groups.
Dexmedetomidine 0.25 μg/kg/hr	Dexmedetomidine 0.75 μg/kg/hr	Heart rate	1066	1330	Systolic blood pressure, heart rate, and SpO2 were decreased, and RSS score was increased significantly at both 20 min and 40 min after injection of dexmedetomidine in the three study groups compared to baseline, without significant differences between the groups.
Dexmedetomidine 0.25 μg/kg/hr	Dexmedetomidine 0.50 μg/kg/hr	Ramsay Sedation Scale score	1130	1330	d RSS score was increased significantly at both 20 min and 40 min after injection of dexmedetomidine in the three study groups compared to baseline, without significant differences between the groups.
Dexmedetomidine 0.25 μg/kg/hr	Dexmedetomidine 0.50 μg/kg/hr	Systolic blood pressure	1066	1330	Systolic blood pressure, heart rate, and SpO2 were decreased, and RSS score was increased significantly at both 20 min and 40 min after injection of dexmedetomidine in the three study groups compared to baseline, without significant differences between the groups.
Dexmedetomidine 0.25 μg/kg/hr	Dexmedetomidine 0.75 μg/kg/hr	Atropine requirements 	12279	12525	The incidence of bradycardia requiring atropine administration and numbers of patients requiring midazolam in each group were comparable between the three groups and showed no statistically significant correlation with the dose of dexmedetomidine
Dexmedetomidine 0.25 μg/kg/hr	Dexmedetomidine 0.50 μg/kg/hr	Ramsay Sedation Scale score	1066	1330	Systolic blood pressure, heart rate, and SpO2 were decreased, and RSS score was increased significantly at both 20 min and 40 min after injection of dexmedetomidine in the three study groups compared to baseline, without significant differences between the groups.
Dexmedetomidine 0.25 μg/kg/hr	Dexmedetomidine 0.75 μg/kg/hr	Atropine requirements 	12279	12527	The incidence of bradycardia requiring atropine administration and numbers of patients requiring midazolam in each group were comparable between the three groups and showed no statistically significant correlation with the dose of dexmedetomidine (
